Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Bullboard Posts
Post by mining4dollarson Jul 23, 2013 3:05pm
319 Views
Post# 21625273

little resistance on heavy volume~!

little resistance on heavy volume~!nice to see the newfound interest in ICO after what has been a few months of heavy selling..

it is evident a lot of the selling in the low 30s/high 20s was a result of the financing; institutions and investors buying huge positions in the placement and selling their shares as close to breakeven @$.35 or below so as to take cash off the table and hold on to their full warrants at $0.40cents for essentially nothing....

It seems like most of this bargain basement selling has worked its way through and I suspect there should be little resistance in the $0.40s.... those who hold  huge positions of the warrants are likely going to let them ride as most that took part in the financing seem to have already sold their common shares  and obviously took part in the first place so as to be positioned prior to results being released..

should be a wild ride over the next few months as resistance eases up and investors look to pile in to establish a position in anticipation of results.. buckle up!



Bullboard Posts